CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in CalciMedica, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +2 vs. Q3 2022
- Shares held
- 11.9M
- +1.12M (+10.4%) vs. Q3 2022
- Total value
- $5.97M
- −$4.20M (−41.3%) vs. Q3 2022
- New holders
- 5
- 4 more added
- Sold out
- 3
- 8 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CALC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $8.39M |
| Q1 2026 | 27 | $592.5K |
| Q4 2025 | 31 | $24.2M |
| Q3 2025 | 31 | $10.9M |
| Q2 2025 | 30 | $5.93M |
| Q1 2025 | 30 | $7.49M |
| Q4 2024 | 29 | $15.1M |
| Q3 2024 | 24 | $13.6M |
| Q2 2024 | 21 | $11.8M |
| Q1 2024 | 20 | $14.8M |
| Q4 2023 | 12 | $1.49M |
| Q3 2023 | 13 | $1.56M |
| Q2 2023 | 13 | $2.72M |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 27 | $5.97M |
| Q3 2022 | 25 | $10.2M |
| Q2 2022 | 25 | $11.7M |
| Q1 2022 | 27 | $13.5M |
| Q4 2021 | 28 | $20.7M |
| Q3 2021 | 27 | $37.0M |
| Q2 2021 | 41 | $63.7M |
| Q1 2021 | 51 | $72.8M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding CalciMedica, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 17 | $0 | 0.00% | −949−98.2% | Reduced |
| Cutler Group LP | 200 | $0 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 1,000 | $1 | 0.00% | +1,000 | New |
| Bank of America Corp | 44 | $22 | 0.00% | +44 | New |
| Wells Fargo & Company | 107 | $54 | 0.00% | +3+2.9% | Added |
| Advisory Services Network, LLC | 631 | $316 | 0.00% | +631 | New |
| BlackRock Inc. | 642 | $321 | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 2,379 | $1.19K | 0.00% | 00.0% | Unchanged |
| Belvedere Trading LLC | 5,300 | $2.65K | 0.00% | +5,300 | New |
| UBS Group AG | 5,376 | $2.69K | 0.00% | +5,167+2,472.2% | Added |
| The PNC Financial Services Group, Inc. | 8,612 | $4.31K | 0.00% | 00.0% | Unchanged |
| Brown Advisory Inc | 10,866 | $5.43K | 0.00% | −7,467−40.7% | Reduced |
| Morgan Stanley | 13,410 | $6.71K | 0.00% | +1,399+11.6% | Added |
| Northern Trust Corp | 16,104 | $8.05K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 19,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 35,073 | $17.5K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 41,900 | $20.9K | 0.00% | −22,100−34.5% | Reduced |
| Susquehanna International Group, LLP | 44,860 | $22.4K | 0.00% | −18,381−29.1% | Reduced |
| Johnson & Johnson | 49,547 | $25.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 66,214 | $33.0K | 0.00% | −179−0.3% | Reduced |
| Bank of New York Mellon Corp | 100,226 | $50.1K | 0.00% | −755−0.7% | Reduced |
| Renaissance Technologies LLC | 156,000 | $78.0K | 0.00% | −44,492−22.2% | Reduced |
| First Manhattan Co | 271,332 | $135.7K | 0.00% | −20,671−7.1% | Reduced |
| Vanguard Group Inc | 419,923 | $210.0K | 0.00% | +1790.0% | Added |
| BML Capital Management, LLC | 1,235,943 | $618.0K | 0.59% | +1,235,943 | New |
| OrbiMed Advisors LLC | 4,163,347 | $2.08M | 0.04% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 5,281,713 | $2.64M | 0.05% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,455−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −114−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −7−100.0% | Sold out |